APA

Burstein H. J., Harris L. N., Marcom P. K., Lambert-Falls R., Havlin K., Overmoyer B., Friedlander R. J., Gargiulo J., Strenger R., Vogel C. L., Ryan P. D., Ellis M. J., Nunes R. A., Bunnell C. A., Campos S. M., Hallor M., Gelman R. & Winer E. P. (20030904). Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Burstein Harold J, Harris Lyndsay N, Marcom P Kelly, Lambert-Falls Rosemary, Havlin Kathleen, Overmoyer Beth, Friedlander Robert J, Gargiulo Janet, Strenger Rochelle, Vogel Charles L, Ryan Paula D, Ellis Mathew J, Nunes Raquel A, Bunnell Craig A, Campos Susana M, Hallor Michele, Gelman Rebecca and Winer Eric P. 20030904. Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Burstein H. J., Harris L. N., Marcom P. K., Lambert-Falls R., Havlin K., Overmoyer B., Friedlander R. J., Gargiulo J., Strenger R., Vogel C. L., Ryan P. D., Ellis M. J., Nunes R. A., Bunnell C. A., Campos S. M., Hallor M., Gelman R. and Winer E. P. (20030904). Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Burstein Harold J, Harris Lyndsay N, Marcom P Kelly, Lambert-Falls Rosemary, Havlin Kathleen, Overmoyer Beth, Friedlander Robert J, Gargiulo Janet, Strenger Rochelle, Vogel Charles L, Ryan Paula D, Ellis Mathew J, Nunes Raquel A, Bunnell Craig A, Campos Susana M, Hallor Michele, Gelman Rebecca and Winer Eric P. Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20030904.